RADLINK ASIA UNVEILS UPGRADED FACILITY FEATURING NEW FULLY-DIGITAL, PET/CT SCANNER

RADLINK ASIA UNVEILS UPGRADED FACILITY FEATURING NEW FULLY-DIGITAL, PET/CT SCANNER

Singapore, 17th August 2017 — RadLink Asia announced that the company’s Molecular Imaging unit, RadLink PET and Cardiac Imaging Centre (“RadLink”), has today unveiled its updated flagship clinic in Paragon Medical Centre. The newly upgraded facility doubles the number of patient rooms and features Southeast Asia’s fully-digital Positron Emission Tomography (“PET”)/Computed Tomography (“CT”) scanner. The new scanner, which is available for use immediately, uses technology that detects smaller1, assisting clinicians in their efforts to diagnose and stage disease. Additionally, radio-isotope doses and scan times are significantly reduced2, hence improving the overall patient experience.

“We are proud to partner with Radlink-Asia in its vision to be a leading provider of diagnostic and molecular imaging in Singapore. The fully digital PET/CT system from GE has the potential to reshape the future of oncology diagnosis, staging and treatment planning with technology that can detect small lesions,” said Myra Eskes, President & CEO, GE Healthcare ASEAN.

The new system brings together the sensitivity of digital detection with innovative reconstruction technology available, combining Time-of-Flight and a PET image reconstruction technology to ensure consistent and accurate Standard Uptake Values (“SUV”) measurements.

This delivers up to a 2-fold improvement in PET quantitation accuracy (SUVmean), and double improvement in image quality3 . With more accurate SUVs, clinicians will be able to more accurately assess treatment response and guide treatment planning decisions as well as conduct research such as quantitative brain studies, boosted by an expanded field-of-view.

The technology has the potential to increase clinicians’ diagnostic service offerings by enabling clinical excellence in oncology and pushing the boundaries of PET user technology in neurology, cardiology and beyond. These expanded capabilities are made possible by increased low-yield tracer capability with protocols that could reduce radiation dosages; allowing clinicians to pursue ground-breaking research without impacting image quality.

Gwendolene Yeo, Managing Director for RadLink Asia commented, “As cancer incidence rates climb across Singapore and the region, and as treatment options become more personalized with precision medicine, it is only natural that Fullerton invests further in RadLink’s molecular imaging business in assisting clinicians to diagnose, stage and treat cancers earlier. Our investment in the new digital PET/CT scanner enacts our mission in raising healthcare standard. We want patients to receive quality care in a more accessible and affordable manner.”

The new fully digital PET/CT scanner has commenced operations at RadLink PET and Cardiac Imaging Centre, located at Paragon Medical Centre.

1 Improved detectability as demonstrated in phantom testing.

2 Compared to Discovery PET/CT 710

3 Improved detectability as demonstrated in phantom testing.

About RadLink Asia

RadLink Asia, a wholly-owned subsidiary of Fullerton Health, is one of Singapore’s largest private provider of outpatient diagnostic and molecular imaging services. RadLink’s diagnostic imaging services include X-ray, Ultrasound, Mammography, Fluoroscopy, Bone Mineral Densitometry, Magnetic Resonance Imaging and Computed Tomography scans. RadLink also provides molecular imaging and services such as Positron Emission Tomography and radionuclide therapy for oncology and bone diseases.

RadLink operates out of their flagship centers, RadLink Diagnostic Imaging Centre and RadLink PET and Cardiac Imaging Centre, in Paragon Medical, located in the heart of Singapore’s medical tourism hub along Orchard Road, as well as six other satellite medical centers offering general radiology services. In addition, RadLink’s radiopharmaceuticals facility in Science Park provides the most comprehensive set of tracers to physicians and hospitals throughout Singapore and has established new tracers used in preclinical research to investigate disease biomarkers.

For more information on RadLink Asia, please visit http://www.radlink.com.sg/

About Fullerton Health
Fullerton Health is a leading provider of corporate healthcare solutions across Asia Pacific. Founded in Singapore in 2011, today we own more than 225 medical centres across 6 countries and have a network of more than 8,000 medical providers around the world. We harness these resources to provide you healthcare that is affordable, yet accessible.

More than 25,000 corporations, from multinational companies to small medium enterprises and government organisations, have chosen to use our services. Our integrated healthcare model and our scale mean we can offer one-stop, cost-effective solutions to our corporate and insurer clients, and better care to our patients.

What’s more, we are strong believers in innovation, and in staying ahead of technological developments. This means we have our own advanced technology system that powers the Fullerton network, and enables this network to grow further. This gives us a continuing ability to improve business performance and efficiency, which in turn creates cost-savings for our customers.

With 50 years of experience listening and caring, and an experienced management team that brings the best from different industries, we are now better poised to transform healthcare in Asia, making it affordable and accessible to those we serve.

For more information on Fullerton Health, please visit http://www.fullertonhealth.com/

About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE Healthcare (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions GE Healthcare helps medical professionals deliver great healthcare to their patients. http://www.gehealthcare.com

Media contact:
Brunswick Group
Will Carnwath, Ben Fry
FULLERTONHEALTH@brunswickgroup.com

GE Healthcare
Denise Nah
Denise.nah@ge.com
+65 9832 9936

Discovery™ MI – ASEAN’s First Fully-Digital PET/CT Scanner

Discovery™ MI – ASEAN’s First Fully-Digital PET/CT Scanner

The newly installed PET/CT in RadLink PET Centre is empowered by a fully digital technology engineered for precision, designed to help diagnose and stage disease earlier and hence better guide your treatment strategies.

Discovery™ MI is the only PET/Ct that brings together the sensitivityof digital detection with the most innovative reconstruction technology available, the combination of Time-of-Flight and Q.Clear. In addition to advancements in reconstruction and detection technology, Discovery™ MI includes diagnostic CT innovations with the Clarity Imaging System, innovative ASIR-V™ iterative reconstruction method and and 5martMAR Virtually eliminating streaks and shadows caused from metal artifacts – resulting in:

Outstanding resolution to improve the detection of small lesions

Up to 82 percent dose reduction at the same image quality in routine imaging across applications

2x increase in spatial resolution

Enhance utilization of limited-access tracers, such as Ga, with highest NEMA sensitivity of any TOF PET/CT

Half the time or half the dose in PET imaging

Provide a more comfortable patient experience with short scan times

SMALL LESION DETECTABILITY

Conventional PET Detection

Patient with history of melamona referred to PET/CT for re-staging and metastatic evaluation.

Smaller lesion detection through digital PET

Discovery™ MI provides more confidence when looking for small metatastic disease in difficult arwa such as the liver.

The exclusive innovative PET image reconstruction technology. Q.Clear and Q.SUV ensure consistent and accurate SUV measurements than conventional methods which delivers not only up to a 2x improvement in PET quantitaion accuracy [SUVmean], but also up to a 2x improvement in image quality. With accurate SUVs, it means more accurately assess treatment response to guide your treatment planning decisions.

1/2 Time, No Compromise

Full Acquisition time 12 min

SUVmax: 7.45 Liver
SUVmean: 20.07

1/2 Acquisition time 6 min

SUVmax: 7.53 Liver
SUVmean: 20.01

Flutemetamol F18 Injection – For early onset of Alzheimer PET scan

Flutemetamol F18 Injection – For early onset of Alzheimer PET scan

The First-and-Only Amyloid Imaging Agent with FDA Approval for Color Image Interpretation

Flutemetamol F18 Injection color images provided accurate amyloid detection

In Study 1:
Hign median sentivity and specificity in autopsy standard-of-truth assesment among five independent, blinded image readers.

In Study 2:

  • Flutemetamol F18 Injection color image reads demonstrated high inter-reader agreement for visual image interpretation (kappa score 0.83, 95% CI [0.79-086]).
  • An intra-reader reproducibility analysis involving two readings for each of 29 duplicate patient images showed: One of the five readers ahd complete agreement for all 29 images, two readers had discordant reads for a single image, and two readers had discordant reads for two images.
  • Intra-reader reproducibility for a subgroup of eight images from aMCI patients showed: All five readers had complete agreement for all duplicate images.
*AMCI – Amnestic Mild Cognitive Impairment

DISCOVER AMYLOID IMAGING IN COLOR

  • A negative Flutemetamol F18 Injection scan indicates sparse to no neuritic plaques and is inconsistent with a neuropathological diagnosis of Alzheimer’s disease at the point of image acquisition
  • A positive Flutemetamol F18 Injection scan indicates moderate to frequent amyloid neuritic plaques
  • Flutemetamol F18 Injection is an adjunct to other diagnostic evaluates

APPROPRIATE SITUATIONS FOR AMYLOID IMAGING

  • With persistent or progressive unexplained MCI
  • Who satisty core clinical criteria for possible Alzheimer’s disease because pf unclear clinical presentation, either a typical clinical course or an etiologically mixed presentation
  • With progressive dementia and a typically early age of onset (usually defined as < 65)

SAFETY OF FLUTEMETAMOL F18 INJECTION

In clinical trials of 761 patients dosed, one experienced a serious hypersensitivity reaction.

  • This reaction was accompanied by flushing, dyspnea, and chest pressure
  • The reaction occured within minutes of administration of Flutemetamol F18 Injection, and the patient recovered with treatment
  • The most commonly reported adverse reactions occured at a rate of <2% and were of mild to moderate intensity
  • The recommended dose is 185 MBq (5 mCi) injected intravenously. The adult effective dose is 5.92 mSv

Revolution CT – the first in Singapore

Revolution CT – the first in Singapore

The “First” Revolution CT in Singapore

First to be launched in Singapore, the high performance GE Revolution CT enhances patient safety and comfort through lower radiation and faster scanning time. Through its high-definition image quality and performance, patients rely less on beta blockers and other contrast agents, enabling a stress-free and comfortable scanning procedure.

Key Differentiators

QUALITY

Images that provide for a confident diagnosis

  • High spatial resolution
  • Low contrast detectability
  • Whisper Drive system to reduce audible noise

COVERAGE

Wide, flexible anatomical coverage

  • Complete organ coverage (160mm)
  • Simple, multi- phase exams
  • Quick answers
  • Temporal resolution (0.28s rotation speed)

SPEED

Fast acquisitions to avoid artifacts
related to motion

  • Gross movement
  • Respiratory motion
  • Pulsatile motion

TECHNOLOGY

Divergent technology solutions

  • 512 slices, whole organ coverage enables 4D imaging
  • High-D iterative reconstruction
  • Wider detector shuttle mode
  • Intelligent motion correction

A Revolution in cardiac CT

ONE BEAT, AT ANY HEART RATE

WHOLE HEART AXIAL IMAGING
MULTI-PHASE FOR HIGHER BPM

HIGH DEFINITION, LOW DOSE

18.2 LP/CM RESOLUTION

ASIR-V*1: REDUCE DOSE UP TO 82%

MOTION FREE WITH OR W/O BETA BLOCKERS

0.28 SEC ROTATION SPEED

SNAPSHOT* FREEZE

ARRHYTHMIA MANAGEMENT

MONITOR AND AVOID BAD BEATS, SCAN IN ONE BEAT

MULTIPLE EXAMS FROM JUST ONE BEAT

CORONARIES, STRESS PERFUSION & FUNCTION

PERSONALIZE 4D DYNAMIC IMAGING

WHOLE HEART PERFUSION & CTA WITHOUT TABLE MOTION

Signa Explorer – the first in S.E.A

Signa Explorer – the first in S.E.A

The “First” SIGNA Explorer MRI in South East Asia

First of its kind in ASEAN, the GE SIGNA Explorer MRI provides for maximum patient comfort through SilentScan; a noise reduction feature that scans at less than 3 decibels above ambient and enhanced motion-free imaging. Low quality images and long, uncomfortable scans will be a thing of the past with the SIGNA Explorer’s improved technology and clinical imaging capabilities.

Key Differentiators

ADVANCED APPLICATIONS

  • Scan faster and increased reconstruction capabilities
  • Scan without noise; completely silent brain exam

NEEDLE FREE APPLICATIONS

  • Non-invasive and minimally invasive scan techniques
  • Remove the need for contrast in many exams

MOTION FREE EXAMS

  • Reduced distortion due to patient motions
  • Allow free breathing
  • More consistent imaging quality & performance

ADVANCED APPLICATIONS

  • SILENT SCAN; reduces noise to less than 3 decibels above ambient
  • FOCUS; increasing resolution with single shot
  • MAVRIC SL: acquisition and reconstruction technique
  • Automated brain exam to simplify and improve throughput in neuro exams

Makeover of RadLink

Makeover of RadLink

Winner of Frost & Sullivan Company of the year award

Winner of Frost & Sullivan Company of the year award

WINNER OF FROST & SULLIVAN 2016 COMPANY OF THE YEAR (SINGAPORE DIAGNOSTIC IMAGING) AWARD

Presented to RadLink Asia for excellence in growth, innovation and leadership towards delivering significant contributions in the diagnostic imaging industry in Singapore.

O-Scan – dedicated extremity MRI

O-Scan – dedicated extremity MRI

O-Scan offers a complete range of high quality imaging capabilities for extremities while providing an optimal patient experience, thanks to its unique ergonomics and open design. It represents the ideal response to today’s healthcare requirements: patient comfort, quality, fast exam times and efficient workflows.

Key Differentiators

O-SCAN FEATURES

  • Open permanent magnet
  • 0.31 Tesla field
  • Ergonomic design
  • Max RF power: 1500W
  • Shimmering: passive
  • Gradient: 20mT/m
  • FOV: 14cm
  • Slew Rate: 40 mT/m/sec

HASSLE-FREE MRI

  • Covers all limbs and joints; knee, ankle, hand and elbow
  • No claustrophobia reaction
  • Maximum patient comfort
  • Offers stability even to larger patients
  • Easy patient positioning with optimized patient bed
  • Short scanning time

IMPRESSIVE IMAGE QUALITY

  • Retains Esaote’s tradition of outstanding image quality
  • Imaging simplicity and friendly operation
  • High performance system with impressive image quality

KNEE FSE T2 SAGITTAL

WRIST XBONE CORONAL

ANKLE STIR SAGITTAL

KNEE XBONE SAGITTAL